PBA
Paradigm Biocapital Advisors’s United Therapeutics UTHR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-307,314
| Closed | -$69.4M | – | 35 |
|
|
2023
Q3 | $69.4M | Buy |
307,314
+68,926
| +29% | +$15.6M | 4.71% | 9 |
|
|
2023
Q2 | $52.6M | Buy |
238,388
+26,496
| +13% | +$5.85M | 4.07% | 9 |
|
|
2023
Q1 | $47.5M | Buy |
211,892
+63,000
| +42% | +$14.1M | 4.5% | 11 |
|
|
2022
Q4 | $41.4M | Buy |
148,892
+8,331
| +6% | +$2.32M | 4.86% | 11 |
|
|
2022
Q3 | $29.4M | Sell |
140,561
-22,505
| -14% | -$4.71M | 3.92% | 10 |
|
|
2022
Q2 | $38.4M | Buy |
163,066
+87,431
| +116% | +$20.6M | 7.66% | 7 |
|
|
2022
Q1 | $13.6M | Buy |
+75,635
| New | +$13.6M | 3.59% | 12 |
|